Zimmer Wins FDA Clearance for PSI Shoulder
August 23, 2013 at 10:47 AM EDT
Zimmer Holdings, Inc. (NYSE: ZMH, a world leader in musculoskeletal care, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Zimmer® Patient Specific Instruments (PSI) Shoulder system to complement its Trabecular Metal™ Reverse Shoulder system for reverse shoulder arthroplasty (RSA) procedures. Zimmer